BLEPHAMIDE Trademark

Trademark Overview

On Friday, May 5, 1961, a trademark application was filed for BLEPHAMIDE with the United States Patent and Trademark Office. The USPTO has given the BLEPHAMIDE trademark a serial number of 72119340. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, May 29, 2021. This trademark is owned by Allergan Pharmaceuticals, Inc.. The BLEPHAMIDE trademark is filed in the Pharmaceutical Products category with the following description:

Medicated Eye Solutions
blephamide

General Information

Serial Number72119340
Word MarkBLEPHAMIDE
Filing DateFriday, May 5, 1961
Status800 - REGISTERED AND RENEWED
Status DateSaturday, May 29, 2021
Registration Number0724725
Registration DateTuesday, December 5, 1961
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicated Eye Solutions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateTuesday, November 2, 1999
Primary Code018
First Use Anywhere DateFriday, April 21, 1961
First Use In Commerce DateFriday, April 21, 1961

Trademark Owner History

Party NameALLERGAN, INC,
Party Type44 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92612
Party NameAllergan Pharmaceuticals, Inc.
Party Type40 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92612
Party NameAllergan Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSanta Ana, CA

Trademark Events

Event DateEvent Description
Saturday, May 29, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, May 29, 2021REGISTERED AND RENEWED (FOURTH RENEWAL - 10 YRS)
Saturday, May 29, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, May 29, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 23, 2021TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 18, 2011REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Tuesday, January 18, 2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, January 12, 2011TEAS SECTION 8 & 9 RECEIVED
Monday, October 27, 2008CASE FILE IN TICRS
Saturday, August 18, 2001REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, August 18, 2001REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, May 11, 2001REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, October 25, 1984REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, December 5, 1981REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)

Related Keywords

blephamide solutions medicated